Alexion Pharmaceuticals, Inc.
Clinical trials sponsored by Alexion Pharmaceuticals, Inc., explained in plain language.
-
New hope for chinese MG patients: ravulizumab trial targets daily symptom relief
Disease control Not yet recruitingThis study tests a drug called ravulizumab in 20 Chinese adults with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The goal is to see if the drug improves daily activities and muscle strength over 26 weeks. Participants must have a specific antibod…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 11:49 UTC
-
Promising drug aims to tame rare autoimmune attacks on the nervous system
Disease control Not yet recruitingThis study tests a drug called ravulizumab in 21 Chinese adults with a rare autoimmune disease called NMOSD, which causes severe attacks on the nerves and spinal cord. The goal is to see if the drug can reduce the number of relapses (flare-ups) and improve daily function. Partici…
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 11:47 UTC